Kytopen raises $30M to commercialize Flowfect Tx Biotechnology company Kytopen has raised $30 million in funding to commercialize Flowfect Tx, a current good manufacturing process-compliant platform for cell therapy manufacturing.Read More
Invicro to partner with NIH on dementia therapies Konica Minolta subsidiary Invicro plans to collaborate with the U.S. National Institutes of Health (NIH) to create a brain imaging and genomics database to help clinicians better identify the risk factors for dementia.Read More
Genelux, Newsoara to collaborate on oncolytic immunotherapies Clinical-stage immunotherapy company Genelux and Shanghai-based Newsoara BioPharma have inked a collaboration and license agreement for the development and marketing of oncolytic immunotherapies, including Genelux's Olvi-Vec.Read More
Acrigen Biosciences secures seed funding Biotechnology firm Acrigen Biosciences has secured seed funding that it plans to use to further develop its pipeline of gene editing technology and genetic medicines.Read More
Sartorius to open new plant in Mich. Life science research firm Sartorius plans to expand its North American business by building a new 130,000-sq-ft plant in Ann Arbor, MI. The new facility is part of Sartorius' ongoing worldwide expansion.Read More
GenScript ProBio, AskGene ink licensing deal GenScript ProBio and AskGene have signed a nonexclusive licensing agreement covering the use of GenScript ProBio's single-domain antibody to target an immune checkpoint target.Read More